1.
Tezer M, tosun veysel, Guntekin U. Pulmonary Hypertension Secondary to Dasatinib Use for the Treatment of Chronic Myeloid Leukemia: Pulmonary Hypertension Due to Dasatinib Use. İJCMBS [Internet]. 2022 Jul. 22 [cited 2024 Apr. 21];2(2):153-6. Available from: https://ijcmbs.com/index.php/ijcmbs/article/view/58